181 related articles for article (PubMed ID: 27588117)
21. Unraveling novel survivin mRNA transcripts in cancer cells using an in-house developed targeted high-throughput sequencing approach.
Adamopoulos PG; Tsiakanikas P; Adam EE; Scorilas A
Genomics; 2021 Jan; 113(1 Pt 2):573-581. PubMed ID: 32980523
[TBL] [Abstract][Full Text] [Related]
22. Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST).
Alaggio R; Turrini R; Boldrin D; Merlo A; Gambini C; Ferrari A; Dall'igna P; Coffin CM; Martines A; Bonaldi L; De Salvo GL; Zanovello P; Rosato A
PLoS One; 2013; 8(11):e80456. PubMed ID: 24303016
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of kappaB-Ras1 expression in gliomas.
Lin H; Wang Y; Zhang X; Liu B; Zhang W; Cheng J
Med Oncol; 2012 Jun; 29(2):1272-9. PubMed ID: 21302000
[TBL] [Abstract][Full Text] [Related]
24. Survivin as a novel target protein for reducing the proliferation of cancer cells.
Li D; Hu C; Li H
Biomed Rep; 2018 May; 8(5):399-406. PubMed ID: 29725522
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of tumor-associated antigens in pediatric and adult ependymomas: implication for vaccine therapy.
Yeung JT; Hamilton RL; Okada H; Jakacki RI; Pollack IF
J Neurooncol; 2013 Jan; 111(2):103-11. PubMed ID: 23179498
[TBL] [Abstract][Full Text] [Related]
26. Potential Involvement of
Gil-Kulik P; Krzyżanowski A; Dudzińska E; Karwat J; Chomik P; Świstowska M; Kondracka A; Kwaśniewska A; Cioch M; Jojczuk M; Nogalski A; Kocki J
Oxid Med Cell Longev; 2019; 2019():8727925. PubMed ID: 30774747
[TBL] [Abstract][Full Text] [Related]
27. Survivin expression is associated with lens epithelial cell proliferation and fiber cell differentiation.
Jarrin M; Mansergh FC; Boulton ME; Gunhaga L; Wride MA
Mol Vis; 2012; 18():2758-69. PubMed ID: 23213276
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies to the inhibitor of apoptosis protein survivin in patients with brain tumors.
Söling A; Plugge EM; Schmitz M; Weigle B; Jacob R; Illert J; Holzhausen HJ; Rainov NG
Int J Oncol; 2007 Jan; 30(1):123-8. PubMed ID: 17143520
[TBL] [Abstract][Full Text] [Related]
29. Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma.
Augello C; Caruso L; Maggioni M; Donadon M; Montorsi M; Santambrogio R; Torzilli G; Vaira V; Pellegrini C; Roncalli M; Coggi G; Bosari S
BMC Cancer; 2009 Apr; 9():125. PubMed ID: 19397802
[TBL] [Abstract][Full Text] [Related]
30. The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma.
Azuhata T; Scott D; Takamizawa S; Wen J; Davidoff A; Fukuzawa M; Sandler A
J Pediatr Surg; 2001 Dec; 36(12):1785-91. PubMed ID: 11733907
[TBL] [Abstract][Full Text] [Related]
31. An Insight into Survivin in Relevance to Hematological, Biochemical and Genetic Characteristics in Tobacco Chewers with Oral Squamous Cell Carcinoma.
Yesupatham ST; Dayanand CD; Azeem Mohiyuddin SM; Harendra Kumar ML
Cells; 2023 May; 12(10):. PubMed ID: 37408277
[TBL] [Abstract][Full Text] [Related]
32. [Expression of the antiapoptotic protein survinin and its gene in primary breast carcinoma].
Shlyakhtunov YA; Klopova VA
Arkh Patol; 2019; 81(2):18-23. PubMed ID: 31006775
[TBL] [Abstract][Full Text] [Related]
33. Monitoring survivin expression in cancer: implications for prognosis and therapy.
Santa Cruz Guindalini R; Mathias Machado MC; Garicochea B
Mol Diagn Ther; 2013 Dec; 17(6):331-42. PubMed ID: 23912862
[TBL] [Abstract][Full Text] [Related]
34. Expression of p16 and Survivin in gliomas and their correlation with cell proliferation.
Gao Y; Li L; Song L
Oncol Lett; 2015 Jul; 10(1):301-306. PubMed ID: 26171019
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of survivin and DNA topoisomerase IIα in diffuse and anaplastic astrocytomas.
Varughese RK; Skjulsvik AJ; Torp SH
Pathol Res Pract; 2017 Apr; 213(4):339-347. PubMed ID: 28214203
[TBL] [Abstract][Full Text] [Related]
36. Survivin, caspase-3 and MIB-1 expression in astrocytic tumors of various grades.
Lebelt A; Rutkowski R; Och W; Jaczun K; Dziemiańczyk-Pakieła D; Milewski R; Mariak Z; Reszeć J
Adv Med Sci; 2016 Sep; 61(2):237-243. PubMed ID: 26995334
[TBL] [Abstract][Full Text] [Related]
37. [Histological and molecular classification of gliomas].
Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
[TBL] [Abstract][Full Text] [Related]
38. RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors.
Mikami M; Masuda T; Kanatani T; Noura M; Umeda K; Hiramatsu H; Kubota H; Daifu T; Iwai A; Hattori EY; Furuichi K; Takasaki S; Tanaka S; Matsui Y; Matsuo H; Hirata M; Kataoka TR; Nakahata T; Kuwahara Y; Iehara T; Hosoi H; Imai Y; Takita J; Sugiyama H; Adachi S; Kamikubo Y
Mol Cells; 2022 Dec; 45(12):886-895. PubMed ID: 36572559
[TBL] [Abstract][Full Text] [Related]
39. Survivin: a bifunctional inhibitor of apoptosis protein.
Johnson ME; Howerth EW
Vet Pathol; 2004 Nov; 41(6):599-607. PubMed ID: 15557069
[TBL] [Abstract][Full Text] [Related]
40. The mitotic regulator Survivin binds as a monomer to its functional interactor Borealin.
Bourhis E; Hymowitz SG; Cochran AG
J Biol Chem; 2007 Nov; 282(48):35018-23. PubMed ID: 17881355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
